Global Lung Cancer Vaccine Market Research Report 2024

List of Figures, Tables and Charts Available in Global Lung Cancer Vaccine Market Research Report 2024

List of Tables
Table 1. Global Lung Cancer Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Lung Cancer Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Lung Cancer Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Lung Cancer Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Lung Cancer Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Lung Cancer Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Lung Cancer Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lung Cancer Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lung Cancer Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Lung Cancer Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lung Cancer Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lung Cancer Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Lung Cancer Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Lung Cancer Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Lung Cancer Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Lung Cancer Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Lung Cancer Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Lung Cancer Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Lung Cancer Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Lung Cancer Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Lung Cancer Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Lung Cancer Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Lung Cancer Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Lung Cancer Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Lung Cancer Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Lung Cancer Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Lung Cancer Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Lung Cancer Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Lung Cancer Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Lung Cancer Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Lung Cancer Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Lung Cancer Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Lung Cancer Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Lung Cancer Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Lung Cancer Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lung Cancer Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Lung Cancer Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Lung Cancer Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Lung Cancer Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Lung Cancer Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Lung Cancer Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Lung Cancer Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Lung Cancer Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Lung Cancer Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Lung Cancer Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Lung Cancer Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Lung Cancer Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Lung Cancer Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Lung Cancer Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Lung Cancer Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Lung Cancer Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Lung Cancer Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Lung Cancer Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Lung Cancer Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Lung Cancer Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Lung Cancer Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Lung Cancer Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Lung Cancer Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Lung Cancer Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Lung Cancer Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Lung Cancer Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Lung Cancer Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Lung Cancer Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Lung Cancer Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Lung Cancer Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline Lung Cancer Vaccine Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Oncothyreon Incorporation Corporation Information
Table 76. Oncothyreon Incorporation Description and Business Overview
Table 77. Oncothyreon Incorporation Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Oncothyreon Incorporation Lung Cancer Vaccine Product
Table 79. Oncothyreon Incorporation Recent Developments/Updates
Table 80. Eli Lily Corporation Information
Table 81. Eli Lily Description and Business Overview
Table 82. Eli Lily Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lily Lung Cancer Vaccine Product
Table 84. Eli Lily Recent Developments/Updates
Table 85. ImClone Systems Corporation Information
Table 86. ImClone Systems Description and Business Overview
Table 87. ImClone Systems Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. ImClone Systems Lung Cancer Vaccine Product
Table 89. ImClone Systems Recent Developments/Updates
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Boehringer Ingelheim Lung Cancer Vaccine Product
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Merck Lung Cancer Vaccine Product
Table 99. Merck Recent Developments/Updates
Table 100. Ono Pharmaceutical Corporation Information
Table 101. Ono Pharmaceutical Description and Business Overview
Table 102. Ono Pharmaceutical Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Ono Pharmaceutical Lung Cancer Vaccine Product
Table 104. Ono Pharmaceutical Recent Developments/Updates
Table 105. CureVac Corporation Information
Table 106. CureVac Description and Business Overview
Table 107. CureVac Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CureVac Lung Cancer Vaccine Product
Table 109. CureVac Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Lung Cancer Vaccine Distributors List
Table 113. Lung Cancer Vaccine Customers List
Table 114. Lung Cancer Vaccine Market Trends
Table 115. Lung Cancer Vaccine Market Drivers
Table 116. Lung Cancer Vaccine Market Challenges
Table 117. Lung Cancer Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lung Cancer Vaccine
Figure 2. Global Lung Cancer Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Lung Cancer Vaccine Market Share by Type in 2023 & 2030
Figure 4. Subunit Vaccines Product Picture
Figure 5. Live Attenuated Vaccines Product Picture
Figure 6. Conjugate Vaccines Product Picture
Figure 7. Inactivated Vaccines Product Picture
Figure 8. Recombinant Vector Vaccines Product Picture
Figure 9. Global Lung Cancer Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Lung Cancer Vaccine Market Share by Application in 2023 & 2030
Figure 11. Man
Figure 12. Woman
Figure 13. Global Lung Cancer Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Lung Cancer Vaccine Market Size (2019-2030) & (US$ Million)
Figure 15. Global Lung Cancer Vaccine Sales (2019-2030) & (K Units)
Figure 16. Global Lung Cancer Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 17. Lung Cancer Vaccine Report Years Considered
Figure 18. Lung Cancer Vaccine Sales Share by Manufacturers in 2023
Figure 19. Global Lung Cancer Vaccine Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Lung Cancer Vaccine Players: Market Share by Revenue in 2023
Figure 21. Lung Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Lung Cancer Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Lung Cancer Vaccine Sales Market Share by Country (2019-2030)
Figure 24. North America Lung Cancer Vaccine Revenue Market Share by Country (2019-2030)
Figure 25. United States Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Lung Cancer Vaccine Sales Market Share by Country (2019-2030)
Figure 28. Europe Lung Cancer Vaccine Revenue Market Share by Country (2019-2030)
Figure 29. Germany Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Lung Cancer Vaccine Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Lung Cancer Vaccine Revenue Market Share by Region (2019-2030)
Figure 36. China Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Lung Cancer Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Lung Cancer Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Lung Cancer Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Lung Cancer Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Lung Cancer Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Lung Cancer Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Lung Cancer Vaccine by Type (2019-2030)
Figure 57. Global Lung Cancer Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Lung Cancer Vaccine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Lung Cancer Vaccine by Application (2019-2030)
Figure 60. Global Lung Cancer Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 61. Lung Cancer Vaccine Value Chain
Figure 62. Lung Cancer Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed